1. Home
  2. CYTH vs SOWG Comparison

CYTH vs SOWG Comparison

Compare CYTH & SOWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTH
  • SOWG
  • Stock Information
  • Founded
  • CYTH 1990
  • SOWG 2010
  • Country
  • CYTH United States
  • SOWG United States
  • Employees
  • CYTH N/A
  • SOWG N/A
  • Industry
  • CYTH Biotechnology: Pharmaceutical Preparations
  • SOWG Packaged Foods
  • Sector
  • CYTH Health Care
  • SOWG Consumer Staples
  • Exchange
  • CYTH Nasdaq
  • SOWG Nasdaq
  • Market Cap
  • CYTH 26.2M
  • SOWG 23.1M
  • IPO Year
  • CYTH N/A
  • SOWG N/A
  • Fundamental
  • Price
  • CYTH $0.80
  • SOWG $2.52
  • Analyst Decision
  • CYTH Buy
  • SOWG Strong Buy
  • Analyst Count
  • CYTH 3
  • SOWG 2
  • Target Price
  • CYTH $0.95
  • SOWG $23.00
  • AVG Volume (30 Days)
  • CYTH 52.2K
  • SOWG 213.0K
  • Earning Date
  • CYTH 03-17-2025
  • SOWG 02-20-2025
  • Dividend Yield
  • CYTH N/A
  • SOWG N/A
  • EPS Growth
  • CYTH N/A
  • SOWG N/A
  • EPS
  • CYTH N/A
  • SOWG 0.21
  • Revenue
  • CYTH $870,725.00
  • SOWG $40,130,971.00
  • Revenue This Year
  • CYTH N/A
  • SOWG $122.17
  • Revenue Next Year
  • CYTH $24.49
  • SOWG N/A
  • P/E Ratio
  • CYTH N/A
  • SOWG $12.61
  • Revenue Growth
  • CYTH N/A
  • SOWG 508.45
  • 52 Week Low
  • CYTH $0.55
  • SOWG $1.98
  • 52 Week High
  • CYTH $2.12
  • SOWG $24.83
  • Technical
  • Relative Strength Index (RSI)
  • CYTH 70.05
  • SOWG 42.25
  • Support Level
  • CYTH $0.76
  • SOWG $2.70
  • Resistance Level
  • CYTH $0.86
  • SOWG $3.00
  • Average True Range (ATR)
  • CYTH 0.07
  • SOWG 0.41
  • MACD
  • CYTH 0.03
  • SOWG 0.12
  • Stochastic Oscillator
  • CYTH 92.58
  • SOWG 30.84

About CYTH Cyclo Therapeutics Inc.

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.

About SOWG Sow Good Inc. Common Stock

Sow Good Inc is engaged in manufacturing and marketing freeze-dried fruits, vegetables, snacks, smoothies, and soups. The company also sells gluten-free granola products under the Sow Good brand. The company is developing a freeze-dried candy market and snack manufacturing to provide consumers with flavorful freeze-dried treats.

Share on Social Networks: